Skip to primary content

Ketamine Leadership Academy

Ketamine Leadership Academy

Main menu

  • About and Disclaimer
  • Emergency-Medicine
  • Anaesthesia
  • Critical Care medicine
  • Pain Medicine
  • Prehospital and Retrieval Medicine
  • Psychiatry
  • Palliative Care medicine
  • Ketamine prescription in Australia
  • Introduction and History of Ketamine
  • The Politics of Medical Ketamine
  • Ketamine Music

Post navigation

← Previous Next →

Successful use of ketamine to treat severe depression with suicidality post-COVID-19 – A case report

Posted on January 10, 2023 by ketaminh

Successful use of ketamine to treat severe depression with suicidality post-COVID-19 – A case report
— Read on www.ncbi.nlm.nih.gov/pmc/articles/PMC9800325/

Share this:

  • Print
  • Email

Like this:

Like Loading...

Related

This entry was posted in Psychiatry and tagged suicidality by ketaminh. Bookmark the permalink.

Ketamine Advocacy Network

Ketamine for Emergency Medicine

Creative Commons License
Ketamine Leadership Academy by Dr Minh Le Cong is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Blog at WordPress.com.
  • Follow Following
    • Ketamine Leadership Academy
      • Join 90 other followers
    • Already have a WordPress.com account? Log in now.
    • Ketamine Leadership Academy
    • Customize
    • Follow Following
    • Sign up
    • Log in
    • Copy shortlink
    • Report this content
    • View post in Reader
    • Manage subscriptions
    • Collapse this bar
%d bloggers like this: